These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21242955)

  • 1. Hyperlipidemic acute pancreatitis: a possible role of antiretroviral therapy with entecavir.
    Durval A; Zamidei L; Bettocchi D; Luzzio MG; Consales G
    Minerva Anestesiol; 2011 Oct; 77(10):1018-21. PubMed ID: 21242955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
    Maratea D; Fadda V; Trippoli S; Messori A
    Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
    Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
    J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
    Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
    Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
    Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
    J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of plasmapheresis in hypertriglyceridemic pancreatitis].
    Jerkovich F; Remón JA; Barretto M; Ciocchini C; Speroni G
    Medicina (B Aires); 2014; 74(1):55-6. PubMed ID: 24561842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment.
    Ozaras R; Mete B; Ceylan B; Ozgunes N; Gunduz A; Karaosmanoglu H; Cagatay A; Gokturk K; Erdem L; Kocak F; Senates E; Tabak F
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):774-80. PubMed ID: 24901822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Hypertriglyceridemia Possibly Masked Acute Pancreatitis and Led to a Difficult Diagnosis in an Obese Patient with Ketoacidosis-onset Type 2 Diabetes.
    Fujishiro M; Horita A; Nakagawara H; Mawatari T; Kishigami Y; Tominaga Y; Moriyama M; Ishihara H
    Intern Med; 2017 Oct; 56(19):2611-2616. PubMed ID: 28883232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
    Park JG; Park SY
    Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tenofovir and entecavir in patients with chronic HBV infection.
    Ceylan B; Yardimci C; Fincanci M; Eren G; Tozalgan U; Muderrisoglu C; Akkoyunlu Y
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2467-73. PubMed ID: 24089225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute pancreatitis caused by hypertriglyceridemia].
    Baranyai T; Terzin V; Vajda A; Wittmann T; Czakó L
    Orv Hetil; 2010 Nov; 151(45):1869-74. PubMed ID: 20980226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
    Köklü S; Tuna Y; Gülşen MT; Demir M; Köksal AŞ; Koçkar MC; Aygün C; Coban S; Ozdil K; Ataseven H; Akin E; Pürnak T; Yüksel I; Ataseven H; Ibiş M; Yildirim B; Nadir I; Küçükazman M; Akbal E; Yüksel O; Başar O; Alkan E; Baykal O
    Clin Gastroenterol Hepatol; 2013 Jan; 11(1):88-94. PubMed ID: 23063679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acute severe hyperlipidemic pancreatitis.
    Kyriakidis AV; Raitsiou B; Sakagianni A; Harisopoulou V; Pyrgioti M; Panagopoulou A; Vasilakis N; Lambropoulos S
    Digestion; 2006; 73(4):259-64. PubMed ID: 16940728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
    Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
    Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B.
    Liu Y; Wang C; Zhong Y; Chen L; Li X; Ji D; Wang H; Xin S; Zoulim F; Xu D
    Antivir Ther; 2010; 15(8):1185-90. PubMed ID: 21149926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing hepatitis B to prevent liver cancer: recent advances.
    Strasser SI
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):409-15. PubMed ID: 24580046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.
    Liaw YF; Raptopoulou-Gigi M; Cheinquer H; Sarin SK; Tanwandee T; Leung N; Peng CY; Myers RP; Brown RS; Jeffers L; Tsai N; Bialkowska J; Tang S; Beebe S; Cooney E
    Hepatology; 2011 Jul; 54(1):91-100. PubMed ID: 21503940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
    Dakin H; Bentley A; Dusheiko G
    Value Health; 2010 Dec; 13(8):922-33. PubMed ID: 20825619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
    Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Gerlich WH
    Intervirology; 2014; 57(3-4):202-11. PubMed ID: 25034489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.